Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Finding useful biomarkers for Parkinson's disease.

Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, Gwinn K, Huang X, Kopil C, Kremer T, Lasch S, Marek K, Marto JA, Merchant K, Mollenhauer B, Naito A, Potashkin J, Reimer A, Rosenthal LS, Saunders-Pullman R, Scherzer CR, Sherer T, Singleton A, Sutherland M, Thiele I, van der Brug M, Van Keuren-Jensen K, Vaillancourt D, Walt D, West A, Zhang J.

Sci Transl Med. 2018 Aug 15;10(454). pii: eaam6003. doi: 10.1126/scitranslmed.aam6003. Review.

PMID:
30111645
2.

JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.

Wharton KA Jr, Quigley C, Themeles M, Dunstan RW, Doyle K, Cahir-McFarland E, Wei J, Buko A, Reid CE, Sun C, Carmillo P, Sur G, Carulli JP, Mansfield KG, Westmoreland SV, Staugaitis SM, Fox RJ, Meier W, Goelz SE.

PLoS One. 2016 May 18;11(5):e0155897. doi: 10.1371/journal.pone.0155897. eCollection 2016.

3.

Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.

Bushnell SE, Zhao Z, Stebbins CC, Cadavid D, Buko AM, Whalley ET, Davis JA, Versage EM, Richert JR, Axtell RC, Steinman L, Medori R.

Neurology. 2012 Aug 7;79(6):531-7. doi: 10.1212/WNL.0b013e318259e123. Epub 2012 May 9.

4.

Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity.

Gao SX, Zhang Y, Stansberry-Perkins K, Buko A, Bai S, Nguyen V, Brader ML.

Biotechnol Bioeng. 2011 Apr;108(4):977-82. doi: 10.1002/bit.22982. Epub 2010 Nov 17.

PMID:
21404269
5.

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.

Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Brück W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R.

Brain. 2011 Mar;134(Pt 3):678-92. doi: 10.1093/brain/awq386.

PMID:
21354971
6.

Quality assessment and analysis of Biogen Idec compound library.

Bowes S, Sun D, Kaffashan A, Zeng C, Chuaqui C, Hronowski X, Buko A, Zhang X, Josiah S.

J Biomol Screen. 2006 Oct;11(7):828-35. Epub 2006 Sep 6.

PMID:
16956997
7.

Driving affinity selection by centrifugal force.

Harlan JE, Egan DA, Ladror US, Snyder S, Tang MI, Buko A, Holzman TF.

Assay Drug Dev Technol. 2003 Aug;1(4):507-19.

PMID:
15090247
8.
10.

Identification of a yellow impurity in aged samples of aqueous butamben suspension: evidence for the oxidative degradation of poly(ethylene glycol).

Ginsburg EJ, Stephens DA, West PR, Buko AM, Robinson DH, Li LC, Bommireddi AR.

J Pharm Sci. 2000 Jun;89(6):766-70.

PMID:
10824135
11.

Inhibition of p56(lck) tyrosine kinase by isothiazolones.

Trevillyan JM, Chiou XG, Ballaron SJ, Tang QM, Buko A, Sheets MP, Smith ML, Putman CB, Wiedeman P, Tu N, Madar D, Smith HT, Gubbins EJ, Warrior UP, Chen YW, Mollison KW, Faltynek CR, Djurić SW.

Arch Biochem Biophys. 1999 Apr 1;364(1):19-29.

PMID:
10087161
12.

Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.

Kati WM, Sham HL, McCall JO, Montgomery DA, Wang GT, Rosenbrook W, Miesbauer L, Buko A, Norbeck DW.

Arch Biochem Biophys. 1999 Feb 15;362(2):363-75.

PMID:
9989947
13.

Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering.

Stassi DL, Kakavas SJ, Reynolds KA, Gunawardana G, Swanson S, Zeidner D, Jackson M, Liu H, Buko A, Katz L.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7305-9.

14.

Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.

Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW.

Drug Metab Dispos. 1997 Apr;25(4):489-501.

PMID:
9107549
15.

Production of brominated tiacumicin derivatives

Hochlowski JE, Jackson M, Rasmussen RR, Buko AM, Clement JJ, Whittern DN, McAlpine JB.

J Antibiot (Tokyo). 1997 Mar;50(3):201-5.

16.

Production of brominated tiacumicin derivatives.

Hochlowski JE, Jackson M, Rasmussen RR, Buko AM, Clement JJ, Whittern DN, McAlpine JB.

J Antibiot (Tokyo). 1997 Mar;50(3):201-5.

17.

Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.

Kumar GN, Rodrigues AD, Buko AM, Denissen JF.

J Pharmacol Exp Ther. 1996 Apr;277(1):423-31. Erratum in: J Pharmacol Exp Ther 1997 Jun;281(3):1506.

PMID:
8613951
18.

Purification of commercial coomassie brilliant blue R-250 and characterization of the chromogenic fractions.

Kundu SK, Robey WG, Nabors P, Lopez MR, Buko A.

Anal Biochem. 1996 Mar 15;235(2):134-40.

PMID:
8833321
19.
20.
21.

Altromycins E, F, G, H and I; additional novel components of the altromycin complex.

Brill GM, Jackson M, Whittern DN, Buko AM, Hill P, Chen RH, McAlpine JB.

J Antibiot (Tokyo). 1994 Oct;47(10):1160-4. No abstract available.

22.

HPLC and PDMS analysis of cleavage products aid in the design of small, stable ANP analogues.

Devine EM Jr, Buko AM, Cepa SP, Davidsen SK, Holleman WH, Marselle CA, Opgenorth TJ, Rockway TW, von Geldern TW.

Int J Pept Protein Res. 1992 Dec;40(6):532-7.

PMID:
1286937
23.

Unexpected behavior of quinolone sulfamates by various mass spectrometric ionization techniques.

Cepa SP, Hill P, Buko AM.

Biol Mass Spectrom. 1992 Mar;21(3):176-8. No abstract available.

PMID:
1315577
24.

Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures.

Hochlowski JE, Mullally MM, Brill GM, Whittern DN, Buko AM, Hill P, McAlpine JB.

J Antibiot (Tokyo). 1991 Dec;44(12):1318-30.

25.

Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator.

Buko AM, Kentzer EJ, Petros A, Menon G, Zuiderweg ER, Sarin VK.

Proc Natl Acad Sci U S A. 1991 May 1;88(9):3992-6.

26.

Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus.

Bohnsack JF, Mollison KW, Buko AM, Ashworth JC, Hill HR.

Biochem J. 1991 Feb 1;273 ( Pt 3):635-40.

27.

Sequence-specific fragmentation from oligopeptides using plasma-desorption mass spectrometry.

Buko AM, Sarin VK.

Rapid Commun Mass Spectrom. 1990 Dec;4(12):541-5.

PMID:
2134195
28.

Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinase.

Kentzer EJ, Buko A, Menon G, Sarin VK.

Biochem Biophys Res Commun. 1990 Aug 31;171(1):401-6.

PMID:
2393398
29.

Altromycins, novel pluramycin-like antibiotics. II. Isolation and elucidation of structure.

Brill GM, McAlpine JB, Whittern DN, Buko AM.

J Antibiot (Tokyo). 1990 Mar;43(3):229-37.

30.

Coumamidines, new broad spectrum antibiotics of the cinodine type. II. Isolation and structural elucidation.

Chen RH, Whittern DN, Buko AM, McAlpine JB.

J Antibiot (Tokyo). 1989 Apr;42(4):533-7.

31.
32.

Phenelfamycins, a novel complex of elfamycin-type antibiotics. II. Isolation and structure determination.

Hochlowski JE, Buytendorp MH, Whittern DN, Buko AM, Chen RH, McAlpine JB.

J Antibiot (Tokyo). 1988 Oct;41(10):1300-15.

33.

Coloradocin, an antibiotic from a new Actinoplanes. II. Identity with luminamicin and elucidation of structure.

Rasmussen RR, Scherr MH, Whittern DN, Buko AM, McAlpine JB.

J Antibiot (Tokyo). 1987 Oct;40(10):1383-93.

34.

New antibiotics from genetically engineered actinomycetes. I. 2-Norerythromycins, isolation and structural determinations.

McAlpine JB, Tuan JS, Brown DP, Grebner KD, Whittern DN, Buko A, Katz L.

J Antibiot (Tokyo). 1987 Aug;40(8):1115-22.

35.

Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination.

Hochlowski JE, Swanson SJ, Ranfranz LM, Whittern DN, Buko AM, McAlpine JB.

J Antibiot (Tokyo). 1987 May;40(5):575-88.

36.
39.

Sequence analysis of polypeptides by collision activated dissociation on a triple quadrupole mass spectrometer.

Hunt DF, Buko AM, Ballard JM, Shabanowitz J, Giordani AB.

Biomed Mass Spectrom. 1981 Sep;8(9):397-408.

PMID:
7306675

Supplemental Content

Support Center